BioSpace News Archive

PsyBio Therapeutics Corp. today announced that Evan Levine , CEO and Chairman of PsyBio, will present at the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on Thursday, October 14th at 10:30 a.m. ET.

Organon (NYSE: OGN), a global women’s health company, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Special 510(k) for technological updates to the Jada® System, intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted.

aTyr Pharma, Inc. today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will participate in a fireside chat as part of the Piper Sandler Virtual Investor Day: Developing Therapeutics for Lung Indications on Friday, October 15, 2021, at 9:00am ET / 6:00am PT.

Nautilus Biotechnology, Inc. today announced it will report financial results for the third quarter of fiscal year 2021 before market open on Tuesday, November 2nd, 2021.

Athenex today announced that it recently held a Type A meeting with the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for oral paclitaxel and encequidar (Oral Paclitaxel) in metastatic breast cancer (mBC).

Aligos Therapeutics, Inc. today announced that the company has started dosing in the first cohort of healthy volunteers in Study ALG-020572-401 (NCT05001022).

atai Life Sciences announced the launch of PsyProtix, a new platform company formed with Chymia LLC, a Duke University biotechnology spinout.

Sirtex Medical announced today that the first procedure of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres in China was successfully performed for a patient with hepatocellular carcinoma (HCC) on Sept. 28, 2021.

Koya Medical recently presented data from the company’s prospective, multi-center, randomized, crossover study (NILE – NCT04908254) comparing Dayspring®, the company’s active compression treatment for lymphedema, to a traditional pneumatic compression pump.

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its third-quarter 2021 financial results will be released on Wednesday, Nov. 3, 2021.